Drug and research giant Bristol-Meyers Squibb is the latest big pharmaceutical company to sign up for a new development in Cambridge, Massachusetts, the nation’s biotech hub.
Bristol-Meyers Squibb Lease Expands US Biotech Hub
Drug Heavyweight Takes 360,000 Square Feet at DivcoWest’s Cambridge Crossing Project
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Companies